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Bloodstream infectionsMatrix-assisted laser desorption/ionization time-of-ﬂight (MALDI-TOF) mass spectrometry (MS) ﬁngerprint-
ing has recently become an effective instrument for rapid microbiological diagnostics and in particular for
identiﬁcation of micro-organisms directly in a positive blood culture. The aim of the study was to evaluate
a collection of 82 stored yeast isolates from bloodstream infection, by MALDI-TOF MS; 21 isolates were iden-
tiﬁed also directly from positive blood cultures and in the presence of other co-infecting micro-organisms. Of
the 82 isolates grown on plates, 64 (76%) were correctly identiﬁed by the Vitek II system and 82 (100%) by
MALDI-TOF MS; when the two methods gave different results, the isolate was identiﬁed by PCR.
MALDI-TOF MS was unreliable in identifying two isolates (Candida glabrata and Candida parapsilosis) directly
from blood culture; however, direct analysis from positive blood culture samples was fast and effective for
the identiﬁcation of yeast, which is of great importance for early and adequate treatment.
© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Candida is an opportunistic pathogen that lives as a commensal of the
gastrointestinal tract in individuals but can cause mucocutaneous candi-
diasis and disseminated infections in immunocompromised and hospital-
izedhosts (Trofa et al., 2008).Candida albicans is themost common fungal
pathogen in humans, although recently a shift towards systemic infec-
tions by non-albicans species has been reported especially in hematolog-
ical, transplanted and intensive care unit (ICU) patients (Bassetti et al.,
2006). Some non-albicans species are intrinsically resistant to the avail-
able antifungal agents used as ﬁrst-line antifungal therapy (Bassetti et
al., 2009; Rodriguez-Tudela et al., 2008); others showan increasedbioﬁlm
forming ability that inﬂuences antifungal susceptibility (Pulcrano et al.,
2012b). For these reasons, the correct identiﬁcation of the infecting or-
ganism has become essential to guide antifungal therapy.
Blood cultures remain the gold standard in themicrobiological diag-
nosis of bacterial or fungal bloodstream infection (BSI): a presumptivestream infection; MALDI-TOF,
; BC, blood culture; ITS, internal
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V. . Open access under CC BY-NC-ND liidentiﬁcation can be suggested by microscopic observations as soon as
growth of micro-organisms is detected by semi-automated incubation
systems, while ﬁnal identiﬁcation was performed by phenotypic
methods. Thus, ﬁnal results are ready very after empiric therapy is
started. MALDI-TOF MS has recently been introduced into routine labo-
ratory procedures and is used as a new approach for rapid identiﬁcation
of bacteria aswell as yeast (vanVeen et al., 2010; Putignani et al., 2011).
Many studies have been performed to evaluate the correct identiﬁca-
tion of Candida clinical isolates at the species level (Marklein et al.,
2009; Dhiman et al., 2011) and recently also below the species level
to make epidemiological analysis of clinical samples (Dieckmann et
al., 2008; Pulcrano et al., 2012a). Other studies used MALDI-TOF MS
for differentiation of pathogens directly from positive blood cultures
(La Scola and Raoult, 2009; Prod'hom et al., 2010; Spanu et al., 2012;
Christner et al., 2010; Ferroni et al., 2010).
The aim of this study was to assess the performance of the Bruker
Biotyper MALDI-TOF MS system for the correct identiﬁcation of Candida
non-albicans isolates frombloodstream infectionby comparing identiﬁca-
tions from plate culture with those directly from blood culture (BC)
bottles.
2. Materials and methods
2.1. Yeast strains
Eighty-two isolates of Candida non-albicans were obtained from
blood culture of patients admitted to the University hospital Federico
II, Naples, between October 2007 and October 2011. All isolates werecense.
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identiﬁcation of species was performed by an automatic Vitek II system
(bioMerieux, Marcy L'Etoile, France). The micro-organisms were rou-
tinely subcultured aseptically onto Sabouraud Dextrose agar plates
(bioMerieux, Marcy l'Etoile, France) and maintained as glycerol stocks
at −80 °C. Candida parapsilosis ATCC 22019 and C. albicans ATCC
10231 were included as quality control strains.
2.2. MALDI-TOF MS species identiﬁcation
The identiﬁcation of yeast isolates from culture plateswas performed
as described by Pulcrano et al. (2012a). Brieﬂy, a loop full of colonies,
grown over night on Sabouraud agar, was suspended in 300 μl of
de-ionized water to which 900 μl of absolute ethanol was added.
After centrifugation at 12,000 ×g for 2 min, the supernatant was
discarded and the pellet was air-dried. The pellet was then dissolved in
20 μl of 70% formic acid and 20 μl of acetonitrile andmixed. The samples
were centrifuged at 12,000 ×g for 2 min, and 1 μl of the clear superna-
tant was spotted in duplicate onto the MALDI target (MSP 96 target
polished steel (MicroScoutTarget) plate; Bruker Daltonics, Bremen,
Germany) and air-dried at room temperature.
The identiﬁcation of yeast isolates from aerobic bottles (PLUS
Aerobic/F, BD, Erembodegem-Aalst, Belgium) was performed from
aliquots (1.8 ml) of positive blood cultures (BACTEC 9240 system, BD,
Erembodegem-Aalst, Belgium) and supplemented with SDS 0.5%. The
mixture was vortexed for 1 min and then centrifuged at 12,000 ×g for
2 min. The pellet waswashed twicewith 1 ml of de-ionizedwater, cen-
trifuged and suspended in 300 μl of de-ionized water plus 900 μl of ab-
solute ethanol. Samples were processed similarly to yeast isolates from
culture plates.
Then each spot was overlaid with 1 μl of HCCA (a-cyano-4-hydroxy
cinnamicacid) matrix solution saturated with organic solvent (50%
acetonitrile and 2.5% triﬂuoroacetic acid) and air-dried completely
before MALDI-TOF MS measurement. MALDI-TOF MS was carried
out with a MALDI Microﬂex LT (Bruker Daltonics, Bremen, Germany).
Peptide mass ﬁngerprint product ion spectra were acquired in a linear
positive mode at a laser frequency of 20 Hz within a mass range from
2,000 to 20,000 Da. For each spectrum, 240 laser shots in 40 shot
steps from different positions of the target spot (random walk move-
ment) were automatically acquired with AutoXecute acquisition con-
trol software (Flex control 3.0; Bruker Daltonics, Bremen, Germany).
The spectra were externally calibrated using the standard calibrant
mixture (Escherichia coli extracts including the additional proteins
RNase A and myoglobin; Bruker Daltonics). Calibration masses were
as follows: RL36, 4365.3 Da; RS32, 5096.8 Da; RS34, 5381.4 Da;
RS33meth, 6255.4 Da; RL29, 7274.5 Da; RS19, 10300.1 Da; RNase A,
13683.2 Da; and myoglobin, 16952.3 Da.
A total of 168 spectra representing the 82 isolates of Candida and
ATCC strains were generated with the automated MALDI-TOF MS
measurements.
Raw spectra were processed using the MALDI BIOTYPER software,
version 2.0, (Bruker Daltonics, MC, Italy) with default settings, and
every peak list generatedwasmatched directly against reference librar-
ies (4,502 species) using the integrated patterns matching algorithm of
BIOTYPER, version 2.0 (Bruker Daltonics MC, Italy). Results were classi-
ﬁed using modiﬁed score values proposed by the manufacturer: a
score ≥ 2 indicated species identiﬁcation, and a score in the range
1.7–1.99 indicated genus identiﬁcation and a score b1.7 denoted no
identiﬁcation.
2.3. Phylogenetic data analysis and MSP construction
For phylogenetic analysis, spectrawere acquired for each isolate and
MSP creation was carried out with the default setting of the Biotyper
software (Desired mass error for the MSP: 200 Da; minimum desired
peak frequency: 25%; maximum desired peak number for the MSP: 70).Each MSP was then assigned to its speciﬁc node on the taxonomy tree.
In order to visualize the relationshipbetween theMSPs, dendrogramclus-
teringwas carried outwith the standard settings of Biotyper 2.0 (distance
measure: correlation; linkage: average).
2.4. Sequence data
When MALDI-TOF MS and Vitek II system reported different identi-
ﬁcation at the species level, the identiﬁcationwas conﬁrmed by PCR and
sequence analysis using speciﬁc primers directed against the internal
transcribed spacer (ITS) region as previously described (Pulcrano et
al., 2012a).
3. Results
The study included two reference strains (C. parapsilosis ATCC
22019 and C. albicans ATCC 10231) and 82 clinical isolates of Candida
non-albicans collected from bloodstream infections of immunocom-
promised, ICU or otherwise critically ill patients hospitalized at the
University Hospital Federico II of Naples, during a period of four
years. Of these, 61/82 were isolated from October 2007 to October
2010, were stored at −80 °C and were identiﬁed only from culture
plate; the other 21/82 were isolated from November 2010 to October
2011 and were identiﬁed directly from blood culture and from culture
plate after 24 h. All 82 isolates were identiﬁed at the species level by
the Vitek II system giving identiﬁcation with a conﬁdence of 99% for
74/82 isolates. The Vitek II failed six identiﬁcations giving three po-
tential species identiﬁcation (Candida guillermondii/Candida famata/
Candida glabrata) and other two identiﬁcations giving no results
also on 24-h plate culture.
MALDI Biotyper identiﬁed all 82 isolates at the species level using
scores of ≥2.0.
Isolates with three potential species identiﬁcation (C. guillermondii/
C. famata/C. glabrata) were identiﬁed by sequencing of the noncoding
ribosomal region internal transcribed spacer (ITS1-4) resulting
C. glabrata (1/6) and C. guillermondii (5/6). Other nine Candida isolates
identiﬁed by the Vitek II with a conﬁdence of 99%, but differently iden-
tiﬁed by MALDI-TOF MS, were identiﬁed by sequencing and the discor-
dant results were resolved in favor of the MALDI Biotyper (Table 1).
Finally, as reported in Table 1, Vitek II misidentiﬁed Lodderomyces
elongisporus as C. parapsilosis and Saccharomyces cerevisiae as Candida
tropicalis. Instead, MALDI-TOF MS gave all correct identiﬁcations at
the species level, in particular for the identiﬁcation of L. elongisporus
where no other biochemical methods could distinguish it from
C. parapsilosis.
For twenty-one isolates, MALDI-TOF MS yeast identiﬁcations
were also performed directly from positive blood cultures, and re-
sults obtained were compared with the ones obtained byMALDI-TOF
MS identiﬁcation from plate culture. When MALDI-TOF identiﬁca-
tions were performed using the colony grown overnight on agar
plates, the correct identiﬁcations were reported for 21/21 isolates
(Table 2). On the contrary, when MALDI-TOF was used directly on
blood cultures, it gave the wrong specie identiﬁcation for one isolate;
it failed to identify C. parapsilosiswhen there were co-infections with
E. coli.
For the 19 isolates that were correctly identiﬁed, the median ID log
(score) was 1.71. Lower ID log(score) values were observed mainly
with C. glabrata isolates.
4. Discussion
C. albicans is the most common species causing invasive candidi-
asis, although the frequency of other non-albicans species, including
C. tropicalis, C. parapsilosis, C. glabrata and Candida krusei, has been
increasing (Bille et al., 2005). Fungal infections affect the duration
of hospitalization and increase treatment costs (Arnold et al.,
Table 1
Performance of MALDI-TOF vs Vitek II for identiﬁcation of Candida species from agar
plates. PCR was used for identiﬁcation of species when MALDI-TOF and Vitek II gave
different results.
Species identiﬁcation Vitek II identiﬁcation MALDI-TOF MS
identiﬁcation









C. glabrata (11) C. glabrata (8)
Candida guillermondii/








Lodderomyces elongisporus (1) C. parapsilosis (1) L. elongisporus (1)
Saccharomyces cerevisiae (1) C. tropicalis (1) S. cerevisiae (1)
C. krusei (1) C. krusei (1) C. krusei (1)
Candida lipolytica (1) C. lipolytica (1) C. lipolytica (1)
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infection and give a prompt and effective treatment to improve pa-
tient outcome.
In particular, the correct identiﬁcation of Candida species could
ﬁnd a survival beneﬁt when early, appropriate antifungal therapy is
administered. In a recent study on C. krusei, it was demonstrated
that early ﬂuconazole therapy did not affect the mortality rate due
to BSI (Grim et al., 2012).
Many diagnostic approaches capable of identifying a large num-
ber of Candida species are available: the standard phenotypical
assays, based on substrate assimilation, which often are time con-
suming and incomplete for the limited spectrum of speciﬁc bio-
chemical patterns discriminatory of species; the new and more
accurate molecular methods, such as genotypic identiﬁcation based onTable 2









1 C. glabrata C. glabrata
2 C. parapsilosis — Escherichia coli
3 C. glabrata C. glabrata
4 C. parapsilosis C. parapsilosis
5 C. glabrata C. glabrata
6 C. tropicalis C. tropicalis
7 C. parapsilosis C. parapsilosis
8 C. parapsilosis C. parapsilosis Staphylococcus haemolyticus
9 C. parapsilosis C. parapsilosis
10 C. parapsilosis C. parapsilosis
11 C. glabrata C. glabrata Staphylococcus epidermidis
12 C. parapsilosis C. parapsilosis
13 C. tropicalis C. tropicalis
14 C. glabrata C. glabrata
15 C. parapsilosis C. parapsilosis S. epidermidis
16 C. glabrata C. glabrata
17 C. parapsilosis C. parapsilosis
18 C. glabrata C. glabrata Staphylococcus hominis
19 C. parapsilosis C. parapsilosis
20 C. parapsilosis C. parapsilosis S. epidermidis
21 C. lipolytica C. glabratasequence of ITS regions, which are expensive, require considerable
expertise and are unsuitable for routine diagnostics; and the
Matrix-assisted laser desorption ionization time-of-ﬂight mass spec-
trometry (MALDI-TOFMS), which emerged several years ago as a pow-
erful tool for improving the quality of microbiological identiﬁcation
and reduces the time needed for determination (Putignani et al.,
2011).
In our study, data collected in 4 years showed a higher proportion
(6% of total) of fungemia episodes occurring in patients admitted to a
neonatal ICU or surgical ward, according to other studies concerning
hospital fungemia (Neu et al., 2009; Zaoutis et al., 2004). In our
study, the predominant non-albicans species isolated is C. parapsilosis,
according to a Spanish study where C. parapsilosis caused 46.8% of
bloodstream infection episodes (Peman et al., 2011), although species
distribution varies according to patients' comorbidities.
The Vitek II system correctly identiﬁed 76% of species, misidentifying
most of C. guillermondii isolates, likely due to the high similarity in bio-
chemical proﬁles generated by C. famata and C. parapsilosis species.
Instead, 100% of isolates growth on plate were identiﬁed at the
species level using MALDI-TOF scores of 2.0; our results are compara-
ble with those obtained in previously published studies, where 92.5%
species were identiﬁed using a score of 2.0 (Marklein et al., 2009). A
score-oriented MSP dendrogram clustered the isolates into ﬁve
main groups deﬁned by species. As expected, L. elongisporus grouped
with the C. parapsilosis cluster (Fig. 1).
To identify yeasts directly from blood cultures without plate sub-
culture, the threshold was set up at scores of 1.8; Dinhman showed
that spectral scores between 1.8 and 2.0 gave accurate identiﬁcation
to the species level with no misidentiﬁcations; a threshold of 1.8 for
species identiﬁcation could suitable in a clinical laboratory (Dhiman
et al., 2011).
Fungemia was reliably detected by MALDI-TOF MS in 20/21 pro-
spective cases; a correct identiﬁcation was obtained in 19/20 cases. In
contrast with our data, Ferreira reported a correct identiﬁcation only
for 1/18 isolate (Ferreira et al., 2011). The unlike results are probably
due to the different protocol used: the initial lysis with detergent and
subsequent centrifugation allowed us to collect fungal cells from BC,
as reported also by Marinach-Patrice (Marinach-Patrice et al., 2010),
who used a similar protocol on simulated BC.
Our failed identiﬁcations occurred for Candida lipolytica, incorrectly
identiﬁed as C. glabrata, and for C. parapsilosis, which remained
unidentiﬁed. In both cases, if yeast cells were less than 106 CFU/ml,
spectra resulted indistinguishable from those of sterile blood cultures
and yield low-scoring incorrect IDs due to arbitrary matching of
non-bacterial peaks. Furthermore, polymicrobial bloodstream infec-
tions, reported for one of them, could hide the detection of fungal
micro-organisms covert by the faster growth of Gramnegative bacterial
agents, present at the same time in the blood of patients. On the con-
trary, it was noted that the co-infections of Gram positive bacteria did
not affect the identiﬁcation of yeast (Klotz et al., 2007; Pulimood et al.,
2002; Ferroni et al., 2010).
Finally, the use of SDS 0.5% to disrupt red blood cell and centrifu-
gation were much faster than other procedures commonly described
for direct MALDI-TOF identiﬁcation from BC (Juiz et al., 2012;
Marinach-Patrice et al., 2010) and probably more useful to recover
fungi in the case of multiple infection with bacteria.
Direct analysis from positive blood culture samples by MALDI-TOF
MS might give correct results earlier than conventional procedures
and allow an early species- or genus-oriented empirical treatment,
both on the basis of the knowledge of the species that show intrinsic
resistance to antifungal agents (Pappas et al., 2009), or strong bioﬁlm
forming ability (Pulcrano et al., 2012b), or other virulence factor, both
by the analysis of the peaks in resistant species as recently evidenced
by De Carolis et al. (2012).
This new approach could improve yeast diagnostics by saving time,
reducing costs of patient hospitalization andminimizing the selection of
Fig. 1. Cluster analysis of matrix-assisted laser desorption ionization time-of-ﬂight mass spectrometry spectra of reference strains (CA ATCC: Candida albicans; CP ATCC: Candida
parapsilosis) and clinical isolates. For C. parapsilosis, only the six misindentiﬁed isolates were reported compared to the ATCC strain. Distance is displayed in relative units. Ck: Can-
dida krusei; Cgu: C. guillermondi; Cgl: Candida glabrata; Ct: Candida tropicalis; Cl: Candida lipolytica; Le: Lodderomyces elongisporus; Sc: Saccharomyces cerevisiae; Cp: C. parapsilosis.
The score-oriented MSP dendrogram was generated with the default setting in Biotyper 2.0.
265G. Pulcrano et al. / Journal of Microbiological Methods 94 (2013) 262–266drug-resistant fungal pathogens with the deletion of harmful empiric
therapy.
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